Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/MESOBLAST-LIMITED-6499027/news/CLINICAL-OUTCOMES-OF-MESOBLAST-S-CELL-THERAPY-IN-END-STAGE-ISCHEMIC-HEART-FAILURE-PRESENTED-AT-AME-30273830/?utm_source=whatsapp&utm_medium=social&utm_campaign=share